Top 15 Most Cited* Value in Health Articles

*Below are the 15 most popular articles for this journal on Blackwell Synergy, based on the Journal Citation Reports of Information Sciences Institute (ISI) as of January 3, 2008. The top 15 Most Read and Cited articles rankings are compiled from all Value in Health issues since May/June 1998, Volume 1, Issue 1.

1. Growth and Quality of the Cost–Utility Literature, 1976–2001
   Peter J. Neumann, ScD, Dan Greenberg, PhD, Natalia V. Olchanski, MS, Patricia W. Stone, PhD, Allison B. Rosen, MD, ScD
   Value in Health, Volume 8 Issue 1 Page 3-9 Jan 2005
   ABSTRACT
    
2. Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report
   Scott Ramsey, MD, PhD (cochair), Richard Willke, PhD (cochair), Andrew Briggs, DPhil, Ruth Brown, MS, Martin Buxton, PhD, Anita Chawla, PhD, John Cook, PhD, Henry Glick, PhD, Bengt Liljas, PhD, Diana Petitti, MD, Shelby Reed, PhD
   Value in Health, Volume 8 Issue 5 Page 521-533 Sep 2005
   ABSTRACT
    
3. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation
   Diane Wild, MSc, Alyson Grove , MSc, Mona Martin, MPA, Sonya Eremenco, MA, Sandra McElroy, BA, Aneesa Verjee-Lorenz, MSc and Pennifer Erikson, PhD
   Value in Health, Volume 8 Issue 2 Page 94-104 Mar 2005
   ABSTRACT
    
4. Persistence and Adherence of Medications for Chronic Overactive Bladder/Urinary Incontinence in the California Medicaid Program
   Yanni F. Yu, MA Michael B. Nichol, PhD Andrew P. Yu, MS Jeonghoon Ahn, PhD
   Value in Health, Volume 8 Issue 4 Page 495-505 Jul 2005
   ABSTRACT
    
5. Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003
   Ágota Szende, MSc, PhD, Nancy K. Leidy, PhD, Dennis Revicki, PhD
   Value in Health, Volume 8 Issue 5 Page 534-548 Sep 2005
   ABSTRACT
    
6. Cost-Effectiveness of Recombinant Human Erythropoietin for Reducing Red Blood Cells Transfusions in Critically Ill Patients
   Robert MacLaren , PharmD and Patrick W. Sullivan , PhD
   Value in Health, Volume 8 Issue 2 Page 105-116 Mar 2005
   ABSTRACT
    
7. Validation of the Restless Legs Syndrome Quality of Life Questionnaire
   Linda Abetz , MA, Susan M. Vallow , BSc, MA, MBA, Jeff Kirsch , PhD, MRPhS, Richard P. Allen , PhD, Tinna Washburn , BA and Christopher J. Earley , MD, PhD
   Value in Health, Volume 8 Issue 2 Page 157-167 Mar 2005
   ABSTRACT
    
8. Probabilistic Analysis of Cost-Effectiveness Models: Statistical Representation of Parameter Uncertainty
   Andrew Briggs, BA, MSc, DPhil
   Value in Health, Volume 8 Issue 1 Page 1-2 Jan 2005
   SUMMARY
    
9. Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?
   Mark Sculpher, PhD, Karl Claxton, DPhil
   Value in Health, Volume 8 Issue 4 Page 433-446 Jul 2005
   ABSTRACT
    
10. The Routine Collation of Health Outcomes Data from Hospital Treated Subjects in the Health Outcomes Data Repository (HODaR): Descriptive Analysis from the First 20,000 Subjects
    Craig J. Currie, PhD, Phil McEwan, PhD, John R. Peters, MD, Tunia C. Patel, MSc, Simon Dixon, MSc
    Value in Health, Volume 8 Issue 5 Page 581-590 Sep 2005
    ABSTRACT
     
11. The Economic Burden of Anemia in Cancer Patients Receiving Chemotherapy
    Gary H. Lyman , MD, MPH, Ernst R. Berndt , PhD, Joel D. Kallich , PhD, M. Haim Erder , PhD, William H. Crown , PhD, Stacey R. Long , MS, Howard Lee , MD, MPH, Xue Song , PhD and Stan N. Finkelstein , MD
    Value in Health, Volume 8 Issue 2 Page 149-156 Mar 2005
    ABSTRACT
     
12. Using Multiple Anchor- and Distribution-Based Estimates to Evaluate Clinically Meaningful Change on the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) Instrument
    Kathleen J. Yost , PhD, Mark V. Sorensen , PhD, Elizabeth A. Hahn , MA, G. Alastair Glendenning , MSc, Ari Gnanasakthy , MBA, MSc and David Cella , PhD
    Value in Health, Volume 8 Issue 2 Page 117-127 Mar 2005
    ABSTRACT
     
13. Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability
    Marco Barbieri, MSc, Michael Drummond, DPhil, Richard Willke, PhD, Jeremy Chancellor, MSc, Bruno Jolain, MD, Adrian Towse, MA, MPhil
    Value in Health, Volume 8 Issue 1 Page 10-23 Jan 2005
    ABSTRACT
     
14. Economic Burden of Patients with Anemia in Selected Diseases
    William B. Ershler, MD, Kristina Chen, PharmD, MS, Eileen B. Reyes, , Robert Dubois, MD, PhD
    Value in Health, Volume 8 Issue 6 Page 629-638 Nov 2005
    ABSTRACT
     
15. Cost-Effectiveness of Face-to-Face Smoking Cessation Interventions: A Dynamic Modeling Study
    Talitha L. Feenstra , PhD , Heleen H. Hamberg-van Reenen , MSc, Rudolf T. Hoogenveen , MSc, Maureen P.M.H. Rutten-van Mölken , PhD
    Value in Health, Volume 8 Issue 3 Page 178-190 May 2005
    ABSTRACT
     

Value in Health Main Page